Becker's Healthcare May 24, 2024
Cameron Cortigiano

An advisory committee to the FDA voted that a blood test that screens for colon and rectal cancers was safe, according to a May 23 report by The New York Times.

The test, designed by Guardant Health, offers an alternative to a colonoscopy or self-administered fecal test for individuals with an average risk for colon and rectal cancers.

However, blood tests are not as effective as colonoscopies at...

Today's Sponsors


Today's Sponsor


Topics: FDA, Govt Agencies, Patient / Consumer, Provider
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
Q&A: How Will the FDA Panel's Decision on MDMA Impact the Future of Psychedelic Medicine?
FDA approves 1st adult vaccine for bacterial pneumonia
FDA Approves Pneumococcal 21-Valent Conjugate Vaccine Capvaxive
FDA tells providers to prepare for supply chain disruptions

Share This Article